Artelo Biosciences, a clinical-stage biopharmaceutical company based in Solana Beach, California, focuses on developing therapeutics targeting lipid-signaling pathways and the endocannabinoid system. Its key programs include ART27.13 for anorexia and ART26.12 for cancer, pain, and anxiety.
ARTL has been in the news recently: Artelo Biosciences, Inc. (ARTL) experienced a significant rise in stock value on Monday, with a trading volume of 11.7 million shares, well above the average of 70.3K. The company reported a 15% increase in revenue for the quarter, attributed to strong demand for its new product line.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
